[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366579-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-366579-en":122},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","role-of-radioiodine-in-cancer-therapy-a-review-of-the-design-and-challenges-in-selecting-radioligands-from-natural-sources","Role of Radioiodine in Cancer Therapy: A Review of the Design and Challenges in Selecting Radioligands from Natural Sources","","Radioiodine-centered radiopharmaceuticals support modern oncology by combining precise diagnosis with targeted therapy, helping reduce side effects. Although iodine-labeled radioligands from natural sources have not been fully explored, evaluations of their design, pharmacokinetics, and clinical relevance remain limited. This review consolidates clinical and experimental evidence on iodine-labeled compounds, assessing labeling approaches such as Iodogen and stable techniques. It also highlights in silico tools to optimize structures, binding, and specificity. Results indicate tumor concentration, improved selectivity, and biological stability, enabling integrated diagnostic and therapeutic use. Continued refinement of stability and biodistribution is essential for precision oncology outcomes across cancer types.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/role-of-radioiodine-in-cancer-therapy-a-review-of-the-design-and-challenges-in-selecting-radioligands-from-natural-sources/366579/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/role-of-radioiodine-in-cancer-therapy-a-review-of-the-design-and-challenges-in-selecting-radioligands-from-natural-sources/366579.png","ImageObject",300,407,{"name":42,"@type":43},"Franzy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"What overall findings are reported regarding these iodine-labeled compounds?","Question",{"text":63,"@type":64},"They tend to concentrate in tumor cells, enhancing selectivity and reducing radiation exposure to non-cancerous tissues. They also show stability in biological environments, supporting integrated diagnostic and therapeutic applications.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},366579,1790829796,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,107,111,114,118],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":104,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":105,"slug":106},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},"Religion & Spirituality",20,"religion-spirituality",{"id":109,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":109,"slug":113},"World Cup","world-cup",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":115,"slug":117},10,"Lifestyle","lifestyle",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":89,"slug":121},19,"General","general",{"code":4,"msg":74,"data":123},{"doc_id":71,"user_id":124,"nickname":42,"user_avatar":125,"doc_module":4,"category_id":104,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":132,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":12,"update_tm":136,"read_time":137,"preview_page_count":33,"preview_urls":138},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Drug Design, Development and Therapy  \n Open Access Full Text Article  \nREVIEW  \nRole of Radioiodine in Cancer Therapy: A Review of the Design and Challenges in Selecting Radioligands from Natural Sources  \nTaufik Muhammad Fakih 1 , 2 , Dhania Novitasari 3 ,4 , Mukh Syaifudin 4 , 5 , Edy Meiyanto 6 , Okid Parama Astirin 7 , Amirah Mohd Gazzali 8 , Muchtaridi Muchtaridi 3 ,4  \n1Doctoral Program of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia; 2Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Islam Bandung, Bandung, West Java, Indonesia; 3Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia; 4Research Collaboration Centre for Theranostic Radiopharmaceuticals, National Research and Innovation Agency (BRIN), Sumedang, West Java, Indonesia; 5Research Center for Radioisotope, Radiopharmaceutical and Biodosimetry Technology, Research Organization for Nuclear Energy, National Research and Innovation Agency (BRIN), Tangerang Selatan, Banten, Indonesia; 6Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia; 7Department of Biology, Faculty of Mathematics and Natural Science, Universitas Sebelas Maret, Surakarta, Central Java, Indonesia; 8School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia  \nCorrespondence: Muchtaridi Muchtaridi, Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, 45363, Indonesia, [Email muchtaridi@unpad.ac.id](Email muchtaridi@unpad.ac.id)  \n\n| Abstract: The use of radioactive isotopes in cancer treatment has marked a pivotal shift in modern medicine, where precise diagnosis and targeted therapy now blend to offer patients more effective care with minimized side effects. Despite significant advancements, the exploration of iodine-labeled radioligands from natural sources remains underdeveloped, and comprehensive evaluations of their design, pharmacokinetics, and clinical relevance are still lacking. This gap has created a pressing need for systematic studies that bridge natural product chemistry with radiopharmaceutical applications. Since the initial application of iodine-131 in thyroid treatments, radioisotopes such as iodine-125 and iodine-131 have gained prominence in oncology due to their dual functionality: they enable accurate imaging while delivering therapeutic radiation directly to tumor cells, reducing harm to surrounding healthy tissues. Recent advancements in radiopharmaceuticals, particularly iodine-labeled compounds, aim to further improve this balance by enhancing cancer treatment efficacy and safety. This review synthesizes findings from clinical and experimental studies that explore a range of iodine-labeled compounds, including natural agents like hypericin, curcumin, and piperine, as well as various synthetic analogs. Key methodologies for incorporating iodine, such as the Iodogen method and other stable-labeling techniques, are evaluated for their impact on the compounds’ pharmacokinetics, stability, and therapeutic performance. Furthermore, in silico methods are highlighted for their contribution to optimize the molecular structures, binding affinities, and specificity, streamlining the selection of high-potential candidates for radiopharmaceutical applications. Findings reveal that iodine-labeled compounds effectively concentrate in tumor cells, enhancing selectivity and reducing radiation exposure to non-cancerous tissues. Notably, these compounds demonstrate stability in biological environments, making them viable options for integrated diagnostic and therapeutic purposes. Moving forward, the ongoing refinement of compound stability and targeted biodistribution is crucial in ensuring these therapies can meet the demands of precisio","cbCaijHivKeihSpr","https://ap.wps.com/l/cbCaijHivKeihSpr","pdf",4833468,31,"English","# Abstract\n# Introduction\n# Drug Design and Development Approaches\n## Iodine Incorporation and Labeling Techniques\n## Pharmacokinetics, Stability, and Therapeutic Performance\n# In Silico Methods for Candidate Selection\n# Tumor Targeting and Diagnostic-Therapy Integration\n# Future Directions and Challenges","[{\"question\":\"What overall findings are reported regarding these iodine-labeled compounds?\",\"answer\":\"They tend to concentrate in tumor cells, enhancing selectivity and reducing radiation exposure to non-cancerous tissues. They also show stability in biological environments, supporting integrated diagnostic and therapeutic applications.\"}]","Role of Radioiodine in Cancer Therapy: A Review of the Design and Challenges in Selecting Radioligands from Natural Sources | PDF",1790166211,78,[139,143,147,151],{"page_no":22,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc0cd299a8d1b02fb301828e17039c58.webp",983,1272,{"page_no":26,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9732dc2c419eeee464d784fffeb81bd2.webp",982,1270,{"page_no":30,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00073ec04b304db10a7aee5ffb186070.webp",981,1269,{"page_no":33,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdb83890488c675e2fe8f5501060d77e.webp",980,1268]